Strategic Timing of Endoscopic Interventions in Infected Necrotizing Pancreatitis

Recruiting N/A Interventional Study
Pancreatitis, Acute Necrotizing
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
104 (estimated)
Sponsor
Orlando Health, Inc. · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Pancreatic necrosis complicates approximately 20-30% of severe acute pancreatitis cases. While many collections resolve without intervention, persistent symptomatic collections-particularly when infected-are associated with significant morbidity and mortality and frequently require procedural management. Current guidelines recommend delaying intervention until collections are fully walled off, typ…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Age ≥ 18 years 2. Patients with symptomatic necrotic collection diagnosed on MRI or CT abdomen/pelvis, defined as fluid collection in the setting of documented pancreatic necrosis that contains necrotic material and encased within a partial or complete wall. 3. Documented or …
Contacts

Ji Young Bang, MD MPH

321-842-2273

jiyoung.bang@orlandohealth.com

CONTACT

Barbara J Broome

321-841-3742

Barbara.Broome@orlandohealth.com

CONTACT